Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03990168
Other study ID # 98-2-75-15001
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2019
Est. completion date April 1, 2020

Study information

Verified date November 2020
Source Iran University of Medical Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to determine the effectiveness of concurrent transcranial direct current stimulation (tDCS) and fluency training in adults with developmental stuttering. We examine the severity of stuttering to investigate the effect of treatnment. In the control group the anodal tDCS and DAF will applied on six consecutive days (1 milliampere [mA] for 20 mins per day), and the control group will received the sham stimulation and DAF for the same time. The severity of stuttering measured by means of tasks and questionnaires before and after treatment sessions and 6 weeks after intervention.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date April 1, 2020
Est. primary completion date April 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - History of developmental stuttering - Participants diagnosed with moderate to severe stuttering - Right handed - Native speaker of Farsi Exclusion Criteria: - Speech or language disorders other than stuttering - Received stuttering treatment within the past year - Hearing loss - History of neurological or psychiatric disorders - History of seizure - Taking any medication that may affect brain function such as anti-depressants

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Anodal tDCS
1 mA anodal tDCS positioned over left superior temporal gyrus and the cathode placed over the occipital lobe. The tDCS stimulation will be delivered for 20 minutes on 6 intervention days.
Behavioral:
fluency intervention/ Delayed Auditory Feedback
Each participant complete three tasks include reading, conversation, and narration. Delayed auditory feedback will be used during these tasks. Each treatment session will take 20 minutes.
Device:
Sham tDCS
The anodal tDCS positioned over left superior temporal gyrus and the cathode placed over the occipital lobe. The current of sham stimulation will involve 30 seconds of stimulation at the beginning of the 20 minutes on 6 intervention days.

Locations

Country Name City State
Iran, Islamic Republic of Narges Moin Tehran

Sponsors (1)

Lead Sponsor Collaborator
Iran University of Medical Sciences

Country where clinical trial is conducted

Iran, Islamic Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mean score of percentage of Stuttered Syllables produced in the speech sample Researcher will calculate the Percentage of Stuttered Syllables (SS %) in the speech sample. Lower percentage of Stuttered Syllables represents better outcomes. Baselines, immediately post-treatment, 1-week post-treatment, 6-weeks post-treatment
Secondary Mean score of the Stuttering Severity Instrument version 4 (SSI-4) The Stuttering Severity Instrument (SSI-4) is a standardized measure of stuttering severity consist of of 3 subscales (frequency, duration and physical concomitants) which are summed to give a total score. The maximum total score of the SSI-4 is 56, which corresponds to the highest stuttering severity. So, lower score represents better outcomes. Baselines, immediately post-treatment, 1-week post-treatment, 6-weeks post-treatment
Secondary Mean score of the Overall Assessment of Speakers Experience of Stuttering (OASES) The OASES is a standardized assessment to measure the effect of stuttering on a person's life that consists of 4 subscales (general information about speech, your reactions to stuttering, communication in daily situations, quality of life). Each sub-test has a score from 1 to 5 in which the number 1 indicates the least negative impact and number 5 shows the most negative impact. These are combined to give a total impact score between 1 and 5, with 5 representing the highest negative impact on person's life. So, higher score represents better outcomes. Baselines, immediately post-treatment, 1-week post-treatment, 6-weeks post-treatment